Buy or sell Ginger stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Ginger Stock

On-Demand behavioral healthcare

Founded

2011

Notable Investors

Kaiser Permanente Ventures

Headquarters

San Francisco CA, US

Total Funding

$63.2M

About Ginger Stock

Ginger is proven to help people get better by providing on-demand coaching, teletherapy, telepsychiatry and guided self-care - right through a smartphone. Within seconds, members have access to a behavioral health coach - 24/7, 365 days a year. Within 48 hours, members can also get a virtual appointment with our therapists and psychiatrists. Ginger is the only behavioral health provider that continuously uses AI & machine learning to improve both access to and quality of care for anyone managing symptoms of stress, anxiety, depression or more complex challenges. Our AI technology has been recognized by the World Economic Forum as a Technology Pioneer, and we were recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company. Leading employers, such as BuzzFeed, Sephora, Pinterest and Chegg, trust Ginger to provide instant access to complete care for all their employees.

Investors

Funding History

October 2011$1.7M
November 2012$6.5M
December 2014$20.0M
September 2019$35.0M

Management

Chief Executive Officer

Russell Glass

Chief Marketing Officer

Christine Hsu Evans

Chief Medical Officer

Omar Dawood

Chief Technology Officer

Alex Boisvert

Chief Finance Officer

Ainslie Mayberry

Chief Commercial Officer

Peter Bridges

Chief Clinical Officer

Dana Udall

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Ginger or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 90K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo